First malaria vaccine to be rolled out in Kenya, Ghana and Malawi

Health cabinet secretary Cleopa Mailu speaks on April 24, 2017 during a high-level forum with senior malaria leaders Co-hosted by WHO and the Ministry of health at a Nairobi hotel. PHOTO | DENNIS ONSONGO | NATION MEDIA GROUP

Source: Daily Nation


24th April 2017

In Summary

  • Beginning 2018, the selected children will receive four doses of the vaccine — once a month for three months and then a fourth dose will be administered 18 months later.
  • RTS,S was developed by British drug manufacturer GlaxoSmithKline in partnership with the PATH Malaria Vaccine Initiative to protect children from the mosquito-borne disease.
  • While RTS,S does not promise full protection against the mosquito-borne disease, it is the most effective potential vaccine so far developed reducing the number of people being hospitalised and blood transfusions.

Read More


Filed in: Editors Picks Tags: , , ,

Related Posts

Bookmark and Promote!

Leave a Reply

Submit Comment


© 2017 Medicalkenya. All rights reserved. XHTML / CSS Valid.